Display options
Share it on

Int J Lab Hematol. 2018 Oct;40(5):521-526. doi: 10.1111/ijlh.12852. Epub 2018 May 13.

Does rotational thromboelastometry accurately predict coagulation status in patients with lupus anticoagulant?.

International journal of laboratory hematology

L Hensch, V Kostousov, K Bruzdoski, M Losos, M Pereira, M de Guzman, S Hui, J Teruya

Affiliations

  1. Division of Transfusion Medicine & Coagulation, Department of Pathology & Immunology, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.
  2. Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX, USA.

PMID: 29756268 DOI: 10.1111/ijlh.12852

Abstract

INTRODUCTION: Rotational thromboelastometry (ROTEM) is increasingly used as a tool for monitoring coagulation status. However, ROTEM is susceptible to misinterpretation due to particular coagulation abnormalities. Here, we report the effects of lupus anticoagulant (LA) on ROTEM.

METHODS: A prospective observational analysis was performed on 16 children with prior studies indicating the presence of LA or antiphospholipid antibodies. ROTEM analysis was performed, and samples were further analyzed by adding phospholipids (PL) to repeat ROTEM analysis if clotting time (CT) abnormalities were discovered with comparison to ROTEM using an equal volume of isotonic saline. Prothrombin time (PT), activated partial thromboplastin time (APTT), dilute Russell's viper venom test (DRVVT), hexagonal phase phospholipid neutralization test (StaClot LA), and factor II activity studies were additionally performed.

RESULTS: Eighteen samples were analyzed by ROTEM. Prolonged CT on INTEM and EXTEM was observed for 11 samples. Samples with CT prolongation had high DRVVT ratios and prolonged APTT. Further, the addition of PL partially reversed this effect, demonstrating PL-dependent inhibition as the cause of CT prolongation. No factor II deficiencies were identified, excluding LA hypoprothrombinemia syndrome as a cause of these findings.

CONCLUSION: Strongly positive LA can prolong the CT on ROTEM studies and lead to erroneous conclusions regarding coagulation status in this patient population.

© 2018 John Wiley & Sons Ltd.

Keywords: coagulation; hemostasis; lupus anticoagulant; viscoelastometry

References

  1. Hartert H. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med. 1951;117:189-203. - PubMed
  2. Anderson L, Quasim I, Steven M, et al. Interoperator and intraoperator variability of whole blood coagulation assays: a comparison of thromboelastography and rotational thromboelastometry. J Cardiothorac Vasc Anesth. 2014;28:1550-1557. - PubMed
  3. Fahrendorff M, Oliveri RS, Johansson PI. The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products - A systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2017;25:39. - PubMed
  4. Schochl H, Forster L, Woidke R, Solomon C, Voelckel W. Use of rotation thromboelastometry (ROTEM) to achieve successful treatment of polytrauma with fibrinogen concentrate and prothrombin complex concentrate. Anaesthesia. 2010;65:199-203. - PubMed
  5. Schochl H, Nienaber U, Hofer G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55. - PubMed
  6. Mallaiah S, Barclay P, Harrod I, Chevannes C, Bhalla A. Introduction of an algorithm for ROTEM-guided fibrinogen concentrate administration in major obstetric haemorrhage. Anaesthesia. 2015;70:166-175. - PubMed
  7. Deppe AC, Weber C, Zimmermann J, et al. Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients. J Surg Res. 2016;203:424-433. - PubMed
  8. Spiezia L, Vasques F, Behr A, et al. Perioperative coagulation assessment of patients undergoing major elective orthopedic surgery. Intern Emerg Med. 2016;11:793-801. - PubMed
  9. Haas T, Goobie S, Spielmann N, Weiss M, Schmugge M. Improvements in patient blood management for pediatric craniosynostosis surgery using a ROTEM(®) -assisted strategy - feasibility and costs. Paediatr Anaesth. 2014;24:774-780. - PubMed
  10. Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228-232. - PubMed
  11. Schmidt DE, Majeed A, Bruzelius M, Odeberg J, Holmström M, Ågren A. A prospective diagnostic accuracy study evaluating rotational thromboelastometry and thromboelastography in 100 patients with von Willebrand disease. Haemophilia. 2017;23:309-318. - PubMed
  12. Görlinger K, Jambor C, Hanke AA, et al. Perioperative Coagulation Management and Control of Platelet Transfusion by Point-of-Care Platelet Function Analysis. Transfus Med Hemother. 2007;34:396-411. - PubMed
  13. Nagler M, Kathriner S, Bachmann LM, Wuillemin WA. Impact of changes in haematocrit level and platelet count on thromboelastometry parameters. Thromb Res. 2013;131:249-253. - PubMed
  14. Conley CL. Disorders of the blood in disseminated lupus erythematosus. Am J Med. 1952;13:1-2. - PubMed
  15. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust N Z J Med. 1990;20:231-236. - PubMed
  16. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med. 1990;112:682-698. - PubMed
  17. Owaidah TM, Qurashi FH, Al Nounou RM, et al. Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies. Hematology. 2003;8:249-257. - PubMed
  18. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295-306. - PubMed
  19. Teruya J, West AG, Suell MN. Lupus anticoagulant assays: questions answered and to be answered. Arch Pathol Lab Med. 2007;131:885-889. - PubMed
  20. Yao K, Zhang L, Zhou H, Tang N, Li D. Plasma Antiphospholipid Antibodies Effects on Activated Partial Thromboplastin Time Assays. Am J Med Sci. 2017;354:22-26. - PubMed
  21. Pathirana S, Wong G, Williams P, et al. The effects of haemodilution with albumin on coagulation in vitro as assessed by rotational thromboelastometry. Anaesth Intensive Care. 2015;43:187-192. - PubMed
  22. Ruttmann TG, Jamest MF, Lombard EH. Haemodilution-induced enhancement of coagulation is attenuated in vitro by restoring antithrombin III to pre-dilution concentrations. Anaesth Intensive Care. 2001;29:489-493. - PubMed
  23. Peng HT, Grodecki R, Rizoli S, Shek PN. A comparative study of tissue factor and kaolin on blood coagulation assays using rotational thromboelastometry and thromboelastography. Blood Coagul Fibrinolysis. 2016;27:31-41. - PubMed
  24. Swadzba J, Iwaniec T, Pulka M, De Laat B, De Groot PG, Musial J. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines. J Thromb Haemost. 2011;9:1776-1783. - PubMed
  25. Darlington DN, Delgado AV, Kheirabadi BS, et al. Effect of hemodilution on coagulation and recombinant factor VIIa efficacy in human blood in vitro. J Trauma. 2011;71:1152-1163. - PubMed
  26. Nielsen JW, Shi J, Wheeler K, Xiang H, Kenney BD. Resource use in pediatric blunt and penetrating trauma. J Surg Res. 2016;202:436-442. - PubMed
  27. Koopman K, Uyttenboogaart M, Hendriks HG, et al. Thromboelastography in patients with cerebral venous thrombosis. Thromb Res. 2009;124:185-188. - PubMed
  28. Miall FM, Deol PS, Barnes TA, et al. Coagulation status and complications of pregnancy. Thromb Res. 2005;115:461-467. - PubMed
  29. Harnett M, Kodali BS. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy. Int J Obstet Anesth. 2006;15:177-178. - PubMed
  30. Breen KA, Hunt BJ. The utility of thromboelastography (TEG) in the management of patients with isolated antiphospholipid antibodies (aPL) or primary antiphospholipid syndrome (PAPS). Blood (ASH Annual Meeting Abstracts). 2010;116:3179. - PubMed
  31. Wallace NH, Dumont A, Burns A, et al. Thromboelastography in the Characterization of Coagulation Status in Antiphospholipid Syndrome. Blood (ASH Annual Meeting Abstracts). 2016;128:4983. - PubMed
  32. Lee ES, Narasimhan U, Kofidis T, Ti LK. Difficulties With the Use of Thromboelastometry in a Patient With Antiphospholipid Syndrome Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth. 2015;29:1016-1020. - PubMed
  33. Samejima Y, Kodaka M, Ichikawa J, et al. Management of a Patient With Antiphospholipid Syndrome Undergoing Aortic Valve Replacement Using the Hepcon Hemostasis Management System Plus and Rotational Thromboelastometry: a Case Report. A A Case Rep. 2017;8:100-104. - PubMed
  34. Reddy S, Friend S, Quintana D, Lockhart EL. Early detection of lupus anticoagulant-hypoprothrombinemia syndrome by rotational thromboelastometry. Blood (ASH Annual Meeting Abstracts). 2015;126:4699. - PubMed
  35. Downey L, Brown ML, Faraoni D, Zurakowski D, DiNardo JA. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients. Anesth Analg. 2017;124:1431-1436. - PubMed
  36. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363:1791-1800. - PubMed

Publication Types